USPTO serial 99072823
COLOGUARD BLOOD
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- STANWOOD, STEPHEN D
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with COLOGUARD BLOOD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sana Hakim
Sana Hakim K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Clinical medical reagents for diagnostic use; medical diagnostic reagents; colorectal cancer screening test kit comprised of molecular medical diagnostic reagents for detecting abnormal biomarkers in blood from cancer or pre-cancerous colon polyps | ACTIVE | — |
| 010 | Blood testing diagnostic apparatus for the detection of disease, namely, cancer, precancer, and diseases or conditions that predispose an individual to cancer; blood testing apparatus for medical diagnostic testing in the fields of cancer or other blood-based diagnostic testing; blood testing apparatus; kits for collecting blood samples comprised primarily of blood testing apparatus, namely, blood collecting tubes and also including stabilization buffers; containers for collecting blood samples for medical purposes; colorectal cancer screening test kit comprised primarily of blood drawing apparatus and also including containers for storing patient blood samples for analysis | ACTIVE | — |
| 042 | Scientific laboratory services in the field of cancer | ACTIVE | — |
| 044 | Providing information to patients in the field of medical diagnostic screening; providing medical information; providing medical diagnostic services, namely, medical analysis services for screening and diagnostic purposes provided by medical laboratories and medical diagnostic testing; providing information in the field of cancer screening; medical laboratory analysis services in the field of cancer relating to the treatment of persons | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Exact Sciences Corporation
- Other trademarks owned by Exact Sciences Corporation
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named COLOGUARD BLOOD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 20, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 19, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 19, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 19, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 13, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 16, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 7, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 7, 2025 | NWAP | NEW APPLICATION ENTERED | — |